Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Lauttia · SciRah

Researcher profile · Semantic Scholar

S. Lauttia

Share profile

S. Lauttia — researcher profile on SciRah

h-index: 5
Works: 10
Citations: 468

Most-cited papers

Human breast cancer cells educate macrophages toward the M2 activation status
S. Sousa, R. Brion, M. Lintunen, P. Kronqvist +8 more
2015Breast Cancer Research379 citations Open access
Semantic Scholar
The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
E. Iivanainen, S. Lauttia, Na Zhang, D. Tvorogov +4 more
2009Microvascular Research35 citations
Semantic Scholar
Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial
Karama Asleh, H. Brauer, A. Sullivan, S. Lauttia +5 more
2020Clinical Cancer Research24 citations Open access
Semantic Scholar
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
L. D. de Boo, K. Jóźwiak, H. Joensuu, H. Lindman +10 more
2022British Journal of Cancer15 citations Open access
Semantic Scholar
Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma
S. Lauttia, H. Sihto, H. Kavola, V. Koljonen +2 more
2014British Journal of Cancer15 citations Open access
Semantic Scholar
193P Adjuvant capecitabine-containing chemotherapy is effective in both BRCA1-like and non-BRCA1-like early-stage TNBC patients
L. D. de Boo, K. Jóźwiak, H. Joensuu, S. Lauttia +9 more
2020Annals of Oncology1 citations Open access
Semantic Scholar
Effects of immune architecture on response to adjuvant capecitabine in triple-negative breast cancer (FinXX trial).
S. Chumsri, Karama Asleh, H. Brauer, D. Hinerfeld +6 more
2019Journal of Clinical Oncology1 citations
Semantic Scholar
Adjuvant Capecitabine-Containing Chemotherapy Benefit and Homologous Recombination Deficiency Status Among Early-Stage TNBC Patients in the FinXX trial
L. D. de Boo, K. Jóźwiak, H. Joensuu, Henrik Lindman +10 more
20200 citations Open access
Semantic Scholar
Abstract P2-03-06: Genomic characterization of 992 primary breast cancers
S. Lauttia, G. Gundem, R. Huovinen, P. Auvinen +3 more
20170 citations
Semantic Scholar
BONE MARROW-DERIVED CELLS IN ANGIOGENESIS AND CANCER
S. Lauttia
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Joensuu×7
Invite
H. Joensuu — researcher profile on SciRah
H. Lindman×3
Invite
H. Lindman — researcher profile on SciRah
L. D. de Boo×3
Invite
L. D. de Boo — researcher profile on SciRah
M. Opdam×3
Invite
M. Opdam — researcher profile on SciRah

×3

Invite

C. van Steenis — researcher profile on SciRah

Invite

R. Kluin — researcher profile on SciRah

Invite

P. Schouten — researcher profile on SciRah

Invite

M. Kok — researcher profile on SciRah

Invite

P. Nederlof — researcher profile on SciRah

Karama Asleh×2

Invite

Karama Asleh — researcher profile on SciRah

Invite

H. Brauer — researcher profile on SciRah

Invite

T. Nielsen — researcher profile on SciRah